Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice

Cancer Research

Volumn 60, Issue 2, 2000, Pages 395-399

  Bishop, Alexander J R ^a   Barlow, Carrolee ^b,c   Wynshaw Boris, Anthony J ^b,d   Schiestl, Robert H ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA STRAND BREAKAGE; GENE DELETION; GENE MUTATION; GENETIC RECOMBINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CROSSES, GENETIC; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HETEROZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 0034650582     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Meyn, M. S. Chromosome instability syndromes: lessons for carcinogenesis. Curr. Top. Microbiol. Immunol., 221: 71-148, 1997.
2. Rotman, G., and Shiloh, Y. ATM: from gene to function. Hum. Mol. Genet., 7: 1555-1563, 1998.
3. Morrell, D., Cromartie, E., and Swift, M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst., 77: 89-92, 1986.
4. Savitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F. S., Shiloh, Y., and Rotman, G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4: 2025-2032, 1995.
5. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynshaw-Boris, A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell, 86: 159-171, 1996.
6. Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., and Baltimore, D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev., 10: 2411-2422, 1996.
7. Elson, A., Wang, Y., Daugherty, C. J., Morton, C. C., Zhou, F., Campos-Torres, J., and Leder, P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA, 93: 13084-13089, 1996.
8. Herzog, K. H., Chong, M. J., Kapsetaki, M., Morgan, J. I., and McKinnon, P. J. Requirement for Aim in ionizing radiation-induced cell death in the developing central nervous system. Science (Washington DC), 280: 1089-1091, 1998.
9. Dynan, W. S., and Yoo, S. Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res., 26: 1551-1559, 1998.
10. Shieh, S. Y., Ikeda, M., Taya, Y., and Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91: 325-334, 1997.
11. Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., and Kastan, M. B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11: 3471-3481, 1997.
12. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
13. Khanna, K. K., and Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene, 8: 3307-3312, 1993.
14. 1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res., 54: 5054-5058, 1994.
15. Cohen, M. M., and Levy, H. P. Chromosome instability syndromes. Adv. Hum. Genet., 18: 43-149, 1989.
16. Kojis, T. L., Gatti, R. A., and Sparkes, R. S. The cytogenetics of ataxia telangiectasia. Cancer Genet. Cytogenet., 56: 143-156, 1991.
17. Brilliant, M. H., Gondo, Y., and Eicher, E. M. Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning. Science (Washington DC), 252: 566-569, 1991.
18. Gondo, Y., Gardner, J. M., Nakatsu, Y., Durham-Pierre, D., Deveau, S. A., Kuper, C., and Brilliant, M. H. High-frequency genetic reversion mediated by a DNA duplication: the mouse pink-eyed unstable mutation. Proc. Natl. Acad. Sci. USA, 90: 297-301, 1993.
19. Gardner, J. M., Nakatsu, Y., Gondo, Y., Lee, S., Lyon, M. F., King, R. A., and Brilliant, M. H. The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science (Washington DC), 257: 1121-1124, 1992.
20. j alleles of pink-eyed dilution locus. Mamm. Genome, 7: 315-316, 1996.
21. Schiestl, R. H., Aubrecht, J., Khogali, F., and Carls, N. Carcinogens induce reversion of the mouse pink-eyed unstable mutation. Proc. Natl. Acad. Sci. USA, 94: 4576-4581, 1997.
22. Schiestl, R. H., Khogali, F., and Carls, N. Reversion of the mouse pink-eyed unstable mutation induced by low doses of x-rays. Science (Washington DC), 266: 1573-1576, 1994.
23. Schiestl, R. H., Aubrecht, J., Yap, W. Y., Kandikonda, S., and Sidhom, S. Polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin induce intrachromosomal recombination in vitro and in vivo. Cancer Res. 57: 4378-4383, 1997.
24. Liao, M. J., Yin, C., Barlow, C., Wynshaw-Boris, A., and van Dyke, T. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction. Mol. Cell. Biol., 19: 3095-3102, 1999.
25. Russell, L. B., Selby, P. B., Von Halle, E., Sheridan, W., and Valcovic, L. Use of the mouse spot testin chemical mutagenesis: interpretation of past data and recommendation for future work. Mutat. Res., 86: 355-379, 1981.
26. Styles, J. A., and Penman, M. G. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens. Mutat. Res., 154: 183-204, 1985.
27. Sokal, R. R., and Rohlf, F. J. Biometrics. San Francisco: W. H. Freeman, 1969.
28. Armstrong, J. F., Kaufman, M. H., Harrison, D. J., and Clarke, A. R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol., 5: 931-936, 1995.
29. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., and Jacks, T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet., 10: 175-180, 1995.
30. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
31. Aubrecht, J., Rugo, R., and Schiestl, R. H. Carcinogens induce intrachromosomal recombination in human cells. Carcinogenesis (Lond.), 16: 2841-2846, 1995.
32. Schiestl, R. H., Igarashi, S., and Hastings, P. J. Analysis of the mechanism for reversion of a disrupted gene. Genetics, 119: 237-247, 1988.
33. Schiestl, R. H. Nonmutagenic carcinogens induce intrachromosomal recombination in yeast. Nature (Lond.), 337: 285-288, 1989.
34. Carls, N., and Schiestl, R. H. Evaluation of the yeast DEL assay with 10 compounds selected by the International Program on Chemical Safety for the evaluation of short-term tests for carcinogens. Mutat. Res., 320: 293-303, 1994.
35. Brennan, R. J., Swoboda, B. E., and Schiestl, R. H. Oxidative mutagens induce intrachromosomal recombination in yeast. Mutat. Res., 308: 159-167, 1994.
36. Brennan, R. J., and Schiestl, R. H. Cadmium is an inducer of oxidative stress in yeast. Mutat. Res., 356: 171-178, 1996.
37. Brennan, R. J., and Schiestl, R. H. Aniline and its metabolites generate free radicals in yeast. Mutagenesis, 12: 215-220, 1997.
38. Wang, D., Kreutzer, D. A., and Essigmann, J. M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res., 400: 99-115, 1998.
39. Rotman, G., and Shiloh, Y. Ataxia-telangiectasia. Is ATM a sensor of oxidative damage and stress? Bioessays, 19: 911-917, 1997.
40. Yan, L. J., Levine, R. L., and Sohal, R. S. Oxidative damage during aging targets mitochondrial aconitase (published erratum: Proc. Natl. Acad. Sci. USA, 95: 1968, 1998), Proc. Natl. Acad. Sci. USA, 94: 11168-11172, 1997.
41. Piret, B., Schoonbroodt, S., and Piette, J. The ATM protein is required for sustained activation of NF-κB following DNA damage. Oncogene, 18: 2261-2271, 1999.
42. Liu, L., and Wells, P. G. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2′-deoxyguanosine in vitro and in viro in murine maternal hepatic and embryonic tissues. Free Radical Biol. Med., 19: 639-648, 1995.
43. el-Hage, S., and Singh, S. M. Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev. Genet., 11: 149-159, 1990.
44. Chen, G., and Lee, E. The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J. Biol. Chem., 271: 33693-33697, 1996.
45. Pandita, T. K., and Hittelman, W. N. The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiat. Res., 131: 214-223, 1992.
46. Meyn, M. S. High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science (Washington DC), 260: 1327-1330, 1993.
47. Thacker, J. The use of integrating DNA vectors to analyse the molecular defects in ionising radiation-sensitive mutants of mammalian cells including ataxia telangiectasia. Mutat. Res., 220: 187-204, 1989.
48. Powell, S., Whitaker, S., Peacock, J., and McMillan, T. Ataxia telangiectasia: an investigation of the repair defect in the cell line AT5BIVA by plasmid reconstitution. Mutat. Res., 294: 9-20, 1993.
49. Ganesh, A., North, P., and Thacker, J. Repair and misrepair of site-specific DNA double-strand breaks by human cell extracts. Mutat. Res., 299: 251-259, 1993.
50. Luo, C. M., Tang, W., Mekeel, K. L., DeFrank, J. S., Anne, P. R., and Powell, S. N. High frequency and error-prone DNA recombination in ataxia telangiectasia cell lines. J. Biol. Chem., 271: 4497-4503, 1996.
51. Dar, M. E., Winters, T. A., and Jorgensen, T. J. Identification of defective illegitimate recombinational repair of oxidatively induced DNA double-strand breaks in ataxia-telangiectasia cells. Mutat. Res., 384: 169-179, 1997.
52. Schmid, C. W., Deka, N., and Matera, A. G. Repetitive human DNA: the shape of things to come. In: K. W. Adolph (ed.), Chromosomes: Eucaryotic, Procaryotic and Viral, Vol. I, pp. 3-29. Boca Raton: CRC Press, 1989.
53. Calabretta, B., Robberson, D. L., Barrera-Saldana, H. A., Lambrou, T. P., and Saunders, G. F. Genome instability in a region of human DNA enriched in Alu repeat sequences. Nature (Lond.), 296: 219-225, 1982.
54. Turker, M. S., Gage, B. M., Rose, J. A., Ponomareva, O. N., Tischfield, J. A., Stambrook, P. J., Barlow, C., and Wynshaw-Boris, A. Solid tissues removed from Atm homozygous deficient mice do not exhibit a mutator phenotype for second-step autosomal mutations. Cancer Res., 59: 4781-4783, 1999.
55. Galli, A., and Schiestl, R. H. On the mechanism of UV and γ-ray-induced intrachromosomal recombination in yeast cells synchronized in different stages of the cell cycle. Mol. Gen. Genet., 248: 301-310, 1995.
56. Pâques, F., and Haber, J. E. Multiple pathways of double-strand break-induced recombination in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev., 63: 349-404, 1999.